Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: A phase 3, double-blind, randomised, parallel-group trial

The Lancet Neurology

Volumn 10, Issue 10, 2011, Pages 881-890

  Kwan, Patrick ^a,b   Brodie, Martin J ^c   Kälviäinen, Reetta ^d   Yurkewicz, Lorraine ^e   Weaver, Jerry ^e   Knapp, Lloyd E ^e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WESTERN INFIRMARY   (United Kingdom)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; PREGABALIN;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; ATTENTION DISTURBANCE; BACKACHE; BLURRED VISION; CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FEMALE; FEVER; FOCAL EPILEPSY; HEADACHE; HUMAN; HYPERTENSION; INCIDENCE; INFLUENZA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MEMORY DISORDER; MONOTHERAPY; MYALGIA; NAUSEA; OROPHARYNGEAL PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SORE THROAT; TOOTH PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; ASIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EPILEPSIES, PARTIAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRIAZINES; YOUNG ADULT;

EID: 80052967975     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70154-5     Document Type: Article

References (35)

1. Banerjee PN, Filippi D, Hauser WA The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009, 85:31-45.
2. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care 2004, National Collaborating Centre for Primary Care, National Institute for Clinical Excellence, London, (accessed Nov 13, 2010). http://www.nice.org.uk/CG020NICEguideline.
3. Kwan P, Brodie MJ Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
4. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007, 68:402-408. Levetiracetam Monotherapy Study Group.
5. Kwan P, Brodie MJ Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003, 60:S2-12.
6. Gamble C, Williamson PR, Chadwick DW, Marson AG A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 2006, 66:1310-1317.
7. Messenheimer J, Mullens EL, Giorgi L, Young F Safety review of adult clinical trial experience with lamotrigine. Drug Saf 1998, 18:281-296.
8. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin Study Group 945-212. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002, 43:993-1000.
9. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1000-1015. on behalf of the SANAD Study group.
10. Delahoy P, Thompson S, Marschner IC Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. BMC Neurol 2010, 10:104.
11. Vartanian MG, Radulovic LL, Kinsora JJ, et al. Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 2006, 68:189-205.
12. Ben-Menachem E Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004, 45(suppl 6):13-18.
13. Brodie MJ Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004, 45(suppl 6):19-27.
14. Baulac M, Leon T, O'Brien TJ, Whalen E, Barrett J A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures. Epilepsy Res 2010, 91:10-19.
15. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981, 22:489-501. Proposal for revised clinical and electroencephalographic classification of epileptic seizures.
16. Recommendation of revision of the note for guidance on clinical investigation of medicinal products in treatment of epileptic disorders (CPMP/EWP/566/98 rev 1) 2000, Committee for Medicinal Products for Human Use, European Medicines Agency, London, (accessed Feb 12, 2011). http://www.emea.europa.eu/pdfs/human/ewp/056698en.pdf.
17. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006, 47:1094-1120.
18. Farrington CP, Manning G Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990, 9:1447-1454.
19. Friede T, Mitchell C, Muller-Velten G Blinded sample size reestimation in non-inferiority trials with binary endpoints. Biomed J 2007, 49:903-916.
20. Gart JJ, Nam JM Approximate interval estimation of the difference in binomial parameters: correction for skewness and extension to multiple tables. Biometrics 1990, 46:637-643.
21. Agresti A, Hartzel J Strategies for comparing treatments on a binary response with multi-centre data. Tutorials in biostatistics, volume 1, statistical methods in clinical studies 2004, 397-421. John Wiley & Sons, Chichester. R.B. D'Agostino (Ed.).
22. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
23. Brodie MJ, Richens A, Yuen AW Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995, 345:476-479. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
24. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010, 49:661-669.
25. Briggs DE, Lee CM, Spiegel K, French JA Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalin. Epilepsy Res 2008, 82:86-92.
26. Arroyo S, Anhut H, Kugler AR, et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004, 45:20-27.
27. Beydoun AA, Uthman BM, Ramsay E, et al. Pregabalin add-on trial: double-blind, multi-center study in patients with partial epilepsy. Epilepsia 2000, 41:253-254.
28. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003, 60:1631-1637.
29. Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005, 46:1926-1936.
30. Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005, 65:1737-1743.
31. Porter RJ, Baulac M, Nohria V Clinical development of drugs for epilepsy: a review of approaches in the United States and Europe. Epilepsy Res 2010, 89:163-175.
32. Leber PD Hazards of inference: the active control investigation. Epilepsia 1989, 30(suppl 1):S57-S63.
33. French JA, Wang S, Warnock B, Temkin N Historical control monotherapy design in the treatment of epilepsy. Epilepsia 2010, 51:1936-1943.
34. Perucca E When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy. Epilepsia 2010, 51:1933-1935.
35. FDA approves Lamictal®XR™(lamotrigine) for conversion to monotherapy for treatment of partial seizures in appropriate patients. Press release GlaxoSmithKline, (accessed May 10, 2011). http://us.gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-407671.htm.